Filing Details
- Accession Number:
- 0001104659-24-025498
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-20 16:01:50
- Reporting Period:
- 2024-02-15
- Accepted Time:
- 2024-02-20 16:01:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1295947 | Prestige Consumer Healthcare Inc. | PBH | Pharmaceutical Preparations (2834) | 201297589 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1776953 | Adel Mekhail | 660 White Plains Road Tarrytown NY 10591 | Evp, Marketing & Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2024-02-15 | 4,000 | $30.19 | 22,681 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.01 Per Share | Disposition | 2024-02-15 | 4,000 | $69.21 | 18,681 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2024-02-15 | 11,549 | $39.98 | 30,230 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.01 Per Share | Disposition | 2024-02-15 | 11,549 | $69.08 | 18,681 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (rights to buy) | Disposition | 2024-02-15 | 4,000 | $0.00 | 4,000 | $30.19 |
| Common Stock | Employee Stock Options (rights to buy) | Disposition | 2024-02-15 | 11,549 | $0.00 | 11,549 | $39.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-05-13 | No | 4 | M | Direct | |
| 0 | 2030-05-04 | No | 4 | M | Direct |
Footnotes
- Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $68.79 to $69.21.
- Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $68.91 to $69.08.
- The options vested and became exercise on the third anniversary of the grant date.
- The options vested in three installments each of 3,850 shares on May 4, 2021 and May 4, 2022 and 3,849 shares on May 4, 2023.
Billionaire Hedge Funds
